POLYLACTIDE AND POLYCAPROLACTONE COPOLYMER AND BLENDS FOR BIORESORBABLE VASCULAR SCAFFOLDS
    2.
    发明申请
    POLYLACTIDE AND POLYCAPROLACTONE COPOLYMER AND BLENDS FOR BIORESORBABLE VASCULAR SCAFFOLDS 审中-公开
    聚合物和聚碳酸酯共聚物和可生物降解血管的混合物

    公开(公告)号:WO2015195794A2

    公开(公告)日:2015-12-23

    申请号:PCT/US2015/036216

    申请日:2015-06-17

    CPC classification number: A61F2/90 A61F2/91 A61L31/041 A61L31/06 A61L31/148

    Abstract: Bioresorbable polymer vascular scaffolds made of combinations of polylactide and polycaprolactone having thin struts in a selected range and sufficient radial strength to support a vessel upon deployment are disclosed. The scaffolds have degradation behavior of molecular weight, radial strength, and mass that are conducive to healing of a vessel including providing patency to a vessel, reduction of radial strength, breaking up, and resorbing to allow return of the vessel to a natural state.

    Abstract translation: 公开了由具有选定范围的薄支柱的聚丙交酯和聚己内酯的组合制成的生物再吸收聚合物血管支架,并具有足够的径向强度以在展开时支撑血管。 支架具有有助于血管愈合的分子量,径向强度和质量的降解行为,包括向容器提供通畅性,降低径向强度,分解和再吸收以允许血管返回到自然状态。

    METHOD TO MINIMIZE CHAIN SCISSION AND MONOMER GENERATION IN PROCESSING OF POLY(L-LACTIDE) STENT
    4.
    发明申请
    METHOD TO MINIMIZE CHAIN SCISSION AND MONOMER GENERATION IN PROCESSING OF POLY(L-LACTIDE) STENT 审中-公开
    减少聚合(L-LACTIDE)STENT加工中的链分离和单体生成的方法

    公开(公告)号:WO2012051195A1

    公开(公告)日:2012-04-19

    申请号:PCT/US2011/055792

    申请日:2011-10-11

    Abstract: Methods of fabricating an implantable medical devices such as stents made from biodegradable polymers are disclosed that reduce or minimize chain scission and monomer generation during processing steps. The method includes processing a poly(L-lactide) resin having an number average molecular weight between 150 to 200 kD in an extruder in a molten state. A poly(L-lactide) tube is formed from the processed resin and a stent is fabricated from the tube. The number average molecular weight of the poly(L-lactide) of the stent after sterilization is 70 to 100 kD.

    Abstract translation: 公开了制造可植入医疗装置的方法,例如由可生物降解的聚合物制成的支架,其可减少或最小化加工步骤期间的链断裂和单体产生。 该方法包括在熔融状态的挤出机中加工数均分子量为150〜200kD的聚(L-丙交酯)树脂。 由处理后的树脂形成聚(L-丙交酯)管,由管制造支架。 灭菌后支架的聚(L-丙交酯)的数均分子量为70〜100kD。

    STENT WITH NUCLEATING AGENT
    8.
    发明申请
    STENT WITH NUCLEATING AGENT 审中-公开
    具有核试剂的STENT

    公开(公告)号:WO2009123824A2

    公开(公告)日:2009-10-08

    申请号:PCT/US2009/036291

    申请日:2009-03-06

    Inventor: WANG, Yunbing

    CPC classification number: A61L31/041 A61L31/06 Y10S623/90 C08L67/04

    Abstract: The use of nucleating agents to manufacture polymeric stents is disclosed. The resulting stents may have increased crystallinity, decreased crystal size, increased mechanical properties, and faster degradation times.

    Abstract translation: 公开了使用成核剂制造聚合物支架。 所得的支架可能具有增加的结晶度,减小的晶体尺寸,增加的机械性能和更快的降解时间。

Patent Agency Ranking